Peptomyc Tackling ‘Undruggable’ Myc For Anticancers

CEO Laura Soucek Takes Issue With Scientific Dogma

Laura Soucek, one of In Vivo’s 2020 Rising Leaders, is hoping to take Barcelona-based start-up Peptomyc to the next level. The company is nearing the clinic with an inhibitor of the transcription factor Myc, which is involved in the regulation of cellular proliferation, but can also be a driver of cancer.

Cancer cells on scientific background.3d illustration
• Source: Shutterstock

More from Innovation

More from In Vivo